• Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Orientbio Inc

+ Add to Watchlist

002630:KS

920 KRW 160 14.81%

As of 02:14:53 ET on 10/21/2014.

Snapshot for Orientbio Inc (002630)

Open: 947 Day's Range: 920 - 990 Volume: 6,101,696
Previous Close: 1,080 52wk Range: 493 - 1,160 1-Yr Rtn: +47.44%

Stock Chart for 002630

No chart data available.
  • 002630:KS 920
  • 1D
  • 1M
  • 1Y
1,080
Interactive 002630 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002630

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) -86.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 92,213.77
Shares Outstanding (M) 100.23
30 Day Average Volume 9,963,152
Price/Book (mrq) 1.7819
Price/Sale (ttm) 4.2580
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 05/23/2003
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002630

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 002630

Orientbio Inc. provides laboratory animals and equipment for medical experiment. The Company also specializes in manufacturing wrist watches and components such as cases, bracelets, and dials.

Jang Jae-JinChairman/CEO/Rep DirectorChoi Suk-JongVice Chairman
Sin Yeong-CheolVice PresidentKim Ju-MinVice President
More Company Profile & Key Executives for 002630

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil